These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 1769904

  • 21. Hormonal therapy for locally advanced prostate cancer.
    Einstein AB.
    NCI Monogr; 1988; (7):171-4. PubMed ID: 3050536
    [Abstract] [Full Text] [Related]

  • 22. Is dehydroepiandrosterone a hormone?
    Labrie F, Luu-The V, Bélanger A, Lin SX, Simard J, Pelletier G, Labrie C.
    J Endocrinol; 2005 Nov; 187(2):169-96. PubMed ID: 16293766
    [Abstract] [Full Text] [Related]

  • 23. [First line therapy in the treatment of metastatic prostate cancer].
    Sakai H, Kanetake H.
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Hormonotherapy for prostate cancer].
    Oishi K, Yoshida O.
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2300-5. PubMed ID: 8259842
    [Abstract] [Full Text] [Related]

  • 29. [Usefulness and positioning of MAB therapy for prostate cancer].
    Akaza H, Chodak GW, Hirao Y.
    Gan To Kagaku Ryoho; 2005 Oct; 32(10):1507-20. PubMed ID: 16227758
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Total androgen blockade in the treatment of hormone-resistant metastasized prostate carcinoma. A literature review.
    Oosterlinck W, Mast P.
    Acta Urol Belg; 1994 Apr; 62(1):67-71. PubMed ID: 8197932
    [Abstract] [Full Text] [Related]

  • 32. Novel concepts in androgen receptor blockade.
    Hsieh AC, Ryan CJ.
    Cancer J; 2008 Apr; 14(1):11-4. PubMed ID: 18303477
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Total androgen blockade for prostate cancer].
    Kagebayashi Y, Ozono S, Takashima K, Yoshikawa M, Hayashi Y, Kaneko Y, Maruyama Y, Hirao Y, Okajima E.
    Hinyokika Kiyo; 1997 Mar; 43(3):197-201. PubMed ID: 9127754
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Endocrine therapy for prostate cancer.
    Damber JE.
    Acta Oncol; 2005 Mar; 44(6):605-9. PubMed ID: 16165920
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hormone therapy of advanced prostate cancer: where we stand today.
    Crawford ED, Nabors W.
    Oncology (Williston Park); 1991 Jan; 5(1):21-30; discussion 30, 32, 37. PubMed ID: 1828686
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.